New professional program launched

Australian pharmacists can now access a professional support program to aid patients using a new weight management treatment.

The Saxenda Pharmacy Program supports patients prescribed Saxenda (liraglutide), a prescription-only private medicine injected subcutaneously.

It is the only TGA-approved GLP-1 analogue for weight management

Launched by manufacturer, Novo Nordisk Pharmaceuticals, the program aims to support patients to ensure better compliance to medicines.

Patients receive timely access to specific program patient information and added value including needles for the